By Professor David Lawson Morris

Conference Abstracts

Bhatt A; Sharma V; Pawar A; Alyami M; Badgwell B; Bijelic L; Brigand C; Cascales P; Cashin P; Cecil T; Choudry HM; Deraco M; Dumont F; de Hingh I; Fotopoulou C; Goere D; Heriot A; Kok N; Lambert L; Levine E; Li Y; Ma R; Mehta S; Mohamed F; Moran B; Gonzalez Moreno S; Morris D; Alzharani N; Nissan A; Pereira Perez F; Piso P; Pocard M; Rau B; Sammartino P; Arjona-Sanchez A; Sardi A; Sideris L; Spiliotis J; Stepanyan A; Van Der Speeten K; Verwaal V; Sugarbaker P; Kazi M; Kusamura S; Glehen O, 2026, 'ASO Visual Abstract: MORPHology and Inter-Observer Variation in Peritoneal Disease Assessment Among Expert Peritoneal Malignancy SUrgeonS-The MORPHEUS Study', in Annals of Surgical Oncology, Vol. 33, pp. 5782 - 5783, http://dx.doi.org/10.1245/s10434-026-19533-0

Kozman MA; Fisher OM; Liauw W; Morris DL, 2023, 'ASO Visual Abstract: Use of Prognostic Factors and Scores in Selection of Patients with Colorectal Cancer Peritoneal Metastasis (CRPM) for Cytoreductive Surgery and Intraperitoneal Chemotherapy (CRS/IPC): Results of an International Survey Among Oncologic Clinicians', in Annals of surgical oncology, Vol. 30, pp. 3346 - 3347, http://dx.doi.org/10.1245/s10434-022-12857-7

Kepenekian V; Kefleyesus A; Petrides G; Barat S; Bonnefoy I; Valle S; Peron J; Alzahrani N; Glehen O; Morris D, 2022, '347P Prognostic impact of signet ring cell proportion in colorectal cancer patients with peritoneal metastases', in Annals of Oncology, Elsevier, Vol. 33, pp. s695, http://dx.doi.org/10.1016/j.annonc.2022.07.485

Karpes J; Dotta D; Fisher O; Shamavonian R; Alzahrani N; Morris DL, 2019, 'Prognostic value of the volume time index (VTI) ratio for patients with appendiceal cancer with peritoneal carcinomatosis treated by cytoreductive surgery and hyperthermic intraperitoneal chemotherapy (CRS/HIPEC).', in Journal of Clinical Oncology, American Society of Clinical Oncology (ASCO), Vol. 37, pp. e15704 - e15704, http://dx.doi.org/10.1200/jco.2019.37.15_suppl.e15704

Ataie-Kachoie PA; Akhter J; Morris DL, 2015, 'Abstract LB-005: Monepantel a new first in class potent inhibitor of P70S6K potentiates the anti-tumor effects of gemcitabine and doxorubicin: In vitro and in vivo studies', in Cancer Research, American Association for Cancer Research (AACR), Vol. 75, pp. lb-005-lb-005, http://dx.doi.org/10.1158/1538-7445.am2015-lb-005

Amini A; Masoumi-Moghaddam S; Ehteda A; Liauw W; Akhter J; Pilai K; Morris DL, 2015, 'Abstract LB-007: Synergistic inhibition of human gastric and colorectal cancers by Bromelain and N-acetylcysteine: An in vivo study', in Cancer Research, American Association for Cancer Research (AACR), Vol. 75, pp. lb-007-lb-007, http://dx.doi.org/10.1158/1538-7445.am2015-lb-007

Masoumi-Moghaddam S; Amini A; Morris DL, 2015, 'P3.04 Sprouty 2 protein, but not Sprouty 4, is an independent prognostic biomarker for human epithelial ovarian cancer', in Annals of Oncology, Elsevier, Vol. 26, pp. ii21, http://dx.doi.org/10.1093/annonc/mdv092.4

Amini A; Masoumi-Moghaddam S; Morris DL, 2015, 'P5.10 Bromelain and N-acetylcysteine inhibit proliferation and survival of gastrointestinal cancer cells: significance of combination therapy', in Annals of Oncology, Elsevier, Vol. 26, pp. ii25, http://dx.doi.org/10.1093/annonc/mdv094.6

Amini A; Masoumi-Moghaddam S; Morris DL, 2015, 'P6.03 In vivo assessment of growth-inhibitory and mucin-depleting effects of bromelain and N-acetylcysteine in peritoneal carcinomatosis models', in Annals of Oncology, Elsevier, Vol. 26, pp. ii28, http://dx.doi.org/10.1093/annonc/mdv095.3

Pillai K; Alalem I; Akhter J; Chua TC; Shehata M; Morris DL, 2014, 'P0202 Effect of non-parallel placement of incircle bipolar radiofrequency ablation probes on volume of tissue ablated with heat sink', in European Journal of Cancer, Elsevier, Vol. 50, pp. e65, http://dx.doi.org/10.1016/j.ejca.2014.03.246

Back to profile page